Wentworth-Douglass Hospital
(603) 742-5252
Decrease (-) Restore Default Increase (+) font size
Physicians
Open Trials

Open Trials

The Clinical Trials in the table below are currently enrolling. 

Trial Type/ID Trial Title

 

Brain Metastases        
NCCTG N107C

 

Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients with Brain Metastases that have been removed by Surgery

 

Metastatic Prostate

A031201

 Enzalutamide With or Without Abiraterone Acetate and Prednisone in Treating Patients with Castration-Resistant Metastatic Prostate Cancer

 

Leukemia/ Lymphoma

E1912

Ibrutinib and Rituximab Compared with Fludarabine Phosphate, and Cyclophosphamide and Rituximab in Patients with Untreated Chronic Lymphocytic Leukemia and Small Lymphoctic Lymphoma

 

Chronic Lymphocytic Leukemia

Alliance A041202

Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients with Previously UNtreated Chronic Lymphocytic Leukemia

 

Breast (New Diagnosis)  
SWOG 1007

 

Standard Adjuvant Endocrine Therapy with versus without Chemotherapy in Patients with 103 Positive Nodes, Hormone Receptor-Positive, and HER2-Negative Breast Cancer

 

 Breast

ECOG E2112

 Exemestane With or Without Entinostat in Treatig Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer that is Locally Advanced or Metastatic

 

Colon  
CALGB 80702

 

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

 

Breast (Stage I-III)
ECOG E1Z11 

 

Anastrozole in Treating Aromatose Inhibitor Musculoskeletal Symptoms in Female Patients with Stage I-III Breast Cancer

 

Breast (Early Stage)

SWOG 1202

 Duloxetine Hydrochloride to Treat Muscle, Bone, and Joint Pain in Patients with Early-Stage Breast Cancer Receiving Hormone Therapy

 

Lung Cancer                
ECOG 5508 

 

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

 

Polycythemia Vera
 INCB-MA-PV-401

 

 Prospective Non-Interventional Study of Disease Progression and Treatment of Patients with Polycythemia Vera in United States Academic or Community Clinical Practices (REVEAL)

 

Esophageal  

RTOG 1010

Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer

 

Multiple Myeloma

E1A11

Bortezomib or Carfilzomib with Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

 

 Spine Metastasis          
RTOG 0631

 

Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis

 

Find What You Need

Events
Careers
Foundation
About Us
Contact
Directions
News
Social Media Agreement
Joint Notice
Web Privacy Policy
WDH Staff Portal

Centers & Services

Cancer Center
Cardiovascular Care
Joint Replacement
Women & Children's
Physician Offices
Other Services

Conditions & Treatments

Health Information
Ebola Information

Support Services

Support Groups
Care-Van
Dental Center
Social Work
Food & Nutrition
Integrative Wellness
Spiritual Care
Concerns & Grievances
Homecare and Hospice

For Patients

Pay Your Bill Online
Pricing Estimates
Financial Assistance
Interpreter Services
Surgery Preparation
Medical Record Request
Advance Directives
Clinical Research & Trials

For Healthcare Professionals

Work and Life
Financial Well-Being
Career and Growth

The Wentworth-Douglass Health System includes:

 

Address

Wentworth-Douglass Hospital
789 Central Avenue, Dover, NH 03820
Phone: (603) 742-5252
Toll free: 1 (877) 201-7100